Rhabditida Infections: Clinical Trials

7 trials for Rhabditida Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1

Follow Rhabditida Infections: new trials by email Literature Review of Rhabditida Infections trials Research Report on Rhabditida Infections

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras
Placebo, Albendazole 400 mg, Albendazole Plus Ivermectin - Trichuriasis, Strongyloidiasis
Phase 3Not yet recruitingMundo Sano Foundation3682026-11-012026-06-23
Better Options for Lymphatic Filariasis Treatment
MoxDA - Moxidectin + Diethylcarbamzine (DEC) + Albendazole, IDA - Ivermectin + DEC + albendazole - Lymphatic Filariasis, Scabies
Phase 3RecruitingMedicines Development for Global Health51002026-09-282026-10-07
Adjunctive Ivermectin Mass Drug Administration for Malaria Control
Ivermectin, Placebo, Dihydroartemisinin-piperaquine - Malaria,Falciparum, Neglected Tropical Diseases
Phase 3UnknownLondon School of Hygiene and Tropical Medicine240002021-05-032022-02-24
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
Albendazole on Day 1, Ivermectin on Day 1, Diethylcarbamazine on day 1 - Trachoma, Yaws
Phase 3CompletedLihir Medical Centre200002018-10-012019-02-28
Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis
Ivermectin - Strongyloidiasis
Phase 3CompletedCentro per le Malattie Tropicali3122013-03-012018-06-14
Treatment of Strongyloides Infection
Ivermectin - Strongyloides Stercoralis Infection, Strongyloidiasis
Phase 3TerminatedAlbert Einstein College of Medicine512012-05-012023-11-30
Ivermectin Versus Albendazole for Chronic Strongyloidiasis
Ivermectin, ivermectin, Albendazole - Chronic Strongyloidiasis
Phase 3CompletedMahidol University902008-07-012017-09-07

Narrower conditions

Strongyloidiasis (7)  ·  Elephantiasis, Filarial (3)  ·  Scabies (3)  ·  Neglected Diseases (2)  ·  Ancylostomiasis (1)  ·  Ascariasis (1)  ·  Hookworm Infections (1)  ·  Malaria (1)  ·  Malaria, Falciparum (1)  ·  Trachoma (1)  ·  Trichuriasis (1)  ·  Yaws (1)

Broader conditions

Helminthiasis (7)  ·  Infections (7)  ·  Nematode Infections (7)  ·  Parasitic Diseases (7)  ·  Secernentea Infections (7)  ·  Ectoparasitic Infestations (3)  ·  Filariasis (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Lymphatic Diseases (3)  ·  Lymphedema (3)  ·  Mite Infestations (3)  ·  Mosquito-Borne Diseases (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Infectious (3)

Interventions

Ivermectin (6)  ·  Albendazole (4)  ·  Azithromycin (1)  ·  Diethylcarbamazine (1)

Sponsors

Albert Einstein College of Medicine (1)  ·  Centro per le Malattie Tropicali (1)  ·  Lihir Medical Centre (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Mahidol University (1)  ·  Medicines Development for Global Health (1)  ·  Mundo Sano Foundation (1)

Countries

Fiji (1)  ·  Guinea-Bissau (1)  ·  Honduras (1)  ·  Italy (1)  ·  Papua New Guinea (1)  ·  Spain (1)  ·  Thailand (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Alejandro Javier Krolewiecki, PhD, MD (1)  ·  Anna R Last, MBChB PhD (1)  ·  Christina M Coyle, MD (1)  ·  Gabriela Matamoros, PhD, MSc, BSc (1)  ·  Lucy John, MD (1)  ·  Yupin Suputtamongkol, MD (1)  ·  Zeno Bisoffi, MD, PhD (1)

Results publications

PMID 21572981, PMID 31558376, PMID 37419638, PMID 39551062